Background S. aureus is one of the causative agents of bovine mastitis. The treatment using conventional antimicrobials has been hampered due to the development of antimicrobial resistance and the ability of the bacteria to form biofilms and localize inside the host cells. Objectives Here, the efficacy of graphene oxide (GO), a carbon-based nanomaterial, was tested against the biofilms and intracellular S. aureus invitro. Following that, the mechanism for the intracellular antimicrobial activities and GO toxicities was elucidated. Methods GO antibiofilm properties were evaluated based on the disruption of biofilm structure, and the intracellular antimicrobial activities were determined by the survival of S. aureus in infected bovine mammary cells following GO exposure. The mechanism for GO intracellular antimicrobial activities was investigated using endocytosis inhibitors. GO toxicity towards the host cells was assessed using a resazurin assay. Results At 100 ug/mL, GO reduced between 30 and 70% of S. aureus biofilm mass, suggesting GO’s ability to disrupt the biofilm structure. At 200 ug/mL, GO killed almost 80% of intracellular S. aureus, and the antimicrobial activities were inhibited when cells were pre-treated with cytochalasin D, suggesting GO intracellular antimicrobial activities were dependent on the actin-polymerization of the cell membrane. At < 250 ug/mL, GO enhanced the viability of the Mac-T cell, and cells were only affected at higher dosages. Conclusion The in vitro efficacy of GO against S. aureus in vitro suggested the compound could be further tested in Vivo to zrecognize its potential as one of the components of bovine mastitis therapy.
Background Staphylococcus aureus (S. aureus) is one of the causative agents of bovine mastitis. The treatment using conventional antimicrobial has been hampered due to the development of antimicrobial resistance, the ability of the bacteria to form biofilms and localize inside the host cells. Objectives Here the efficacy of graphene oxide (GO), a carbon-based nanomaterial was tested against the biofilms and intracellular S. aureus in- vitro. Following that, the mechanism for the intracellular antimicrobial activities and GO toxicities were elucidated. Methods GO antibiofilm properties were evaluated based on the disruption of biofilm structure, and the intracellular antimicrobial activities were determined by the survival of S. aureus in infected bovine mammary cells following GO exposure. The mechanism for GO intracellular antimicrobial activities were investigated using endocytosis inhibitors. GO toxicity towards the host cells were assessed using resazurin assay. Results At 100 mg/L GO reduced between 30–70% of S. aureus biofilm mass, suggesting GO’s ability to disrupt the biofilm structure. At 200 mg/L GO killed almost 80% of intracellular S. aureus and the antimicrobial activities were inhibited when cells were pre-treated with cytochalasin D, suggesting GO intracellular antimicrobial activities were dependent on the actin-polymerisation of the cell membrane. At < 250 mg/L, GO enhanced the Mac-T cells viability, and cells were only affected at higher dosages. Conclusion GO efficacy against S. aureus in vitro suggested the compound could be further tested in- vivo to recognise its potential as one of the components of bovine mastitis therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.